Yield Theory

Julia Letlow · ABBV

Julia Letlow's ABBV trades

Every AbbVie Inc. transaction Julia Letlow reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
4
Buys / sells
2 / 2
Disclosed range
$4K – $60K
Last filed
2026-01-13

ABBV transactions reported by Julia Letlow

4 of 4 rows
TypeOwner
AbbVie Inc. Common Stock
ABBV
SaleSelf$1,001 - $15,0002026-01-13
#20030977
AbbVie Inc. Common Stock
ABBV
PurchaseSelf$1,001 - $15,0002026-01-13
#20030977
AbbVie Inc. Common Stock
ABBV
SaleSelf$1,001 - $15,0002026-01-13
#20030977
AbbVie Inc. Common Stock
ABBV
PurchaseSelf$1,001 - $15,0002026-01-13
#20030977

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Julia Letlow and ABBV — questions

Did Julia Letlow buy or sell ABBV?

House Clerk filings for 2025 and 2026 show 2 purchases and 2 sales of AbbVie Inc. (ABBV) reported by Julia Letlow, between 2024-10-23 and 2025-12-08. Reported owner: Self.

How much ABBV did Julia Letlow trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K – $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last ABBV filing by Julia Letlow?

The most recent periodic transaction report containing a ABBV row was filed on 2026-01-13. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with AbbVie Inc.. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Julia Letlow ABBV disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included